Log In
Print this Print this

Minocycline foam (FMX101) (formerly FXFM244)

Also known as: FMX-101

  Manage Alerts
Collapse Summary General Information
Company Foamix Pharmaceuticals Ltd.
DescriptionTopical 4% minocycline foam, a semi-synthetic derivative of tetracycline
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAcne
Indication DetailsTreat moderate to severe acne
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today